Mayo Clinic Laboratories > Therapeutics > Addiction rehabilitation monitoring > Comprehensive drug profiles

Comprehensive Drug profiles

Increase confidence through precision analysis

The Clinical and Forensic Toxicology Laboratory offers high-resolution, accurate mass spectrometry-based profiles to identify parent drugs and metabolites, including prescription drugs and illicit substances, to support patient rehabilitation and recovery. Utilization of emerging technologies in our assays enables increased specificity to detect the lowest levels of substances, which correlates to a reduction in false positives. This decreases the need for unnecessary confirmatory testing often required with traditional immunoassay screens.

Comprehensive Drug profiles test menu

Addiction medicine profile Addiction medicine profile
Controlled substance monitoring enhanced profile Controlled substance monitoring enhanced profile

Addiction medicine profile

Our comprehensive addiction medicine profile can help identify polysubstance use disorder as well as assess and manage patients at risk for substance use disorder.

Key testing

  • ADMPU | Addiction Medicine Profile with Reflex, 22 Drug Classes, High Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
    • Detects recent drug use involving alcohol, amphetamine-type stimulants, barbiturates, benzodiazepines, cocaine, opioids, nicotine, and THC-COOH in urine.
    • Identifies polysubstance use disorder and/or abuse to reduce adverse drug reactions (e.g., overdose toxicity).
    • Useful for the assessment and management of patients at risk for substance use disorders.
    • Distinguishes active from passive tobacco use.
    • No charge for specimens identified as invalid due to adulteration (profile component Mayo ID: ADULT).
    • Facilitates the appropriate use of testing methodologies to minimize costs and improve patient outcomes.

Highlights

New high-resolution urine drug testing profile

Bringing together advanced testing technology, unparalleled expertise, and a patient-focused approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol, marijuana, and nicotine, enabling clarity on substance use and precision insights that propel treatment.

Learn more
Addiction rehab monitoring assay

Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories' unique approach to urine drug testing for addiction rehabilitation. Designed to guide and monitor therapy, the comprehensive profile tests for the most commonly used substances, including alcohol and nicotine, for a complete picture of a patient’s substance use.

Learn more

Controlled substance monitoring enhanced profile

In instances where nicotine testing is not required, our enhanced controlled substance monitoring profile can provide accurate answers about other substance use.

Key testing

INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.